Quantcast

French Motorist’s Throttle Jams At 125 MPH

Feb 17, 13 French Motorist’s Throttle Jams At 125 MPH

It started out as a normal weekend day for 36-year-old Frank Lecerf. He left his home in northern France to do some shopping at the local market. Not having any thought that he would make world news and end up in Belgium with the authorities as an escort.

He drives a Renault Laguna, which had been modified for disabled drivers. As he made his way north on the dual carriageway at 60 MPH, the vehicle’s speed control jammed and when he applied the brake the car accelerated instead of slowing down. Each time he tried the brake it went faster, until he reached 125 MPH.

The situation worsened, as other vehicles swerved and darted out of the way to avoid crashing with the ever-increasing speed of his vehicle. Even as scary as it must have been, he was able to contact the authorities, who immediately sent a squad of cars to clear the way to avoid a major accident.  Three toll stations were along that stretch of highway and were warned beforehand to raise their barriers when the speeding convoy approached.

The ordeal began from his home in Pont-de-Metz, France, which is near the northern city of Amiens. It took him north on the carriageway through Calais and Dunkirk even crossing the border into Belgium before finally ending the frightening experience an hour later and close to 125 miles from his home. Fortunately he was able to maneuver the Renault into a ditch in Alveringem, Belgium when it finally ran out of gas.

During the crisis a Renault technician was on the phone with the police and tried to find a solution to the dilemma, but to no avail. The car just kept speeding up the road with no sign of rectifying itself.

“My life flashed before me,” he told the French newspaper Le Courrier Picard in an interview. “I just wanted it to stop.”

Lecerf had mentioned that this was not the first time the throttle had stuck. Renault looked at the car and assured him that the car was fine. A legal complaint has been filed by Lecerf, and his lawyer stated it would be an “endangerment of a person’s life” claim.

During the ordeal, Lecerf had two epileptic seizures, but was able to keep the car under control. He sustained no other injuries from the incident.

References:

http://www.guardian.co.uk/world/2013/feb/13/french-driver-200kmh-car-chase

http://www.foxnews.com/leisure/2013/02/14/french-driver-crashes-after-being-trapped-in-speeding-125mph-car-with-no-brakes/

Image Credit: lexan / Shutterstock.com

Facebook Twitter Pinterest Plusone Digg Reddit Stumbleupon Email

About 

My Name is Gerard Leblond. I was born in 1961, and grew up in Maine. I am happily married to a wonderful wife. Have been working construction since my dad put a hammer in my hand when I was five. I have a son, daughter, step daughter, and two step sons. I have many grandchildren Besides writing for redOrbit, I enjoy writing stories in the hopes of one day becoming a published author. I also write computer programs, make graphic designs and build and code computer games. I am a huge sports enthusiast, with racing as my favorite. I grew up in Maine, moved away with my wonderful wife for several years, and now have returned and once again reside in Maine.

Send Gerard an email

1 Comment

  1. Anonymous /

    Bristol-Myers Squibb of new antipsychotic drugs gratifying results of Phase III clinical trials

    Bristol-Myers Squibb Company the experimental antipsychotic aripiprazole (Abilitat) recently released test results show that the drug may help control the symptoms associated with schizophrenia. The drug is currently undergoing Phase III clinical trials. Aspects will be the fourth quarter of 2001 to be submitted to the FDA. Bristol-Myers Squibb, [url=http://www.medchemexpress.com/product/Aripiprazole.html]aripiprazole[/url] was significantly superior to placebo in controlling symptoms of schizophrenia. The drug is taken once a day, compared to some schizophrenia drugs on the market, with the advantage. The trial involved 404 patients, but
    The company said the drug has proved significantly superior to placebo “control the positive and negative symptoms of schizophrenia.
    If approved live, aripiprazole Zyprexa (Zyprexa) with Johnson & Johnson’s Risperdal (Risperdal), Eli Lilly and Company and Pfizer’s new drug Geodon compete. The Biotest Myers Squibb Company said that the side effects can be found as a selling point Abilitat. In clinical trials, an increased risk of Geodon with QT prolongation, Bristol-Myers Squibb company said its products this abnormal ratio increase was not statistically significant. The company also reported that “only a small part of the patients in the medication during clinical visible weight gain. The above tests Risperdal its
    The results showed that risperidone was superior to placebo. But the Risperdal to increase the level of prolactin, while aripiprazole not make the increase.

    Medchemexpress Can provide the above product,its website:[url=http://www.medchemexpress.com]www.medchemexpress.com[/url]

    [url=http://www.medchemexpress.com/product/LDN193189-hydrochloride.html]LDN193189 hydrochloride[/url]
    [url=http://www.medchemexpress.com/product/CH5424802.html]CH5424802[/url]
    [url=http://www.medchemexpress.com/product/GSK1838705A.html]GSK1838705A[/url]
    [url=http://www.medchemexpress.com/product/ASP3026.html]ASP3026[/url]
    [url=http://www.medchemexpress.com/product/ALK-inhibitor-1.html]ALK inhibitor[/url]
    [url=http://www.medchemexpress.com/product/GNF-2.html]GNF-2[/url]
    [url=http://www.medchemexpress.com/product/NVP-BHG712.html]NVP-BHG712[/url]
    [url=http://www.medchemexpress.com/product/MK-2206.html]MK 2206[/url]
    [url=http://www.medchemexpress.com/product/AZD-7762.html]AZD-7762[/url]

Leave a Comment

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>